user

Serum collagen fragments and outcomes in hormone receptor-positive metastatic breast cancer.

被引：1
|
作者：
Leitzel, Kim
Ali, Suhail M.
Vasekar, Monali K.
Nagabhairu, Vinod
Marks, Eric
Ali, Ayesha
Krecko, Laura
Willumsen, Nicholas
Leeming, Diana Julie
Karsdal, Morten Asser
Lipton, Allan
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
[2] Lebanon VAMC, Lebanon, NH USA
[3] Penn State Coll Med, Hershey, PA 17033 USA
[4] Univ Southern Denmark, Odense, Denmark
[5] Nord Bioscience A S, Herlev, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [32] Molecular alterations in the androgen receptor and associated clinical outcomes in hormone receptor-positive/HER2-metastatic breast cancer
    Dai, Charles
    Niemierko, Andrzej
    Vidula, Neelima
    Spring, Laura M.
    Wander, Seth A.
    Medford, Arielle J.
    Hesler, Katherine A.
    Malvarosa, Giuliana
    Peppercorn, Jeffrey
    Juric, Dejan
    Isakoff, Steven J.
    Moy, Beverly
    Ellisen, Leif W.
    Bardia, Aditya
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [33] Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer
    Akiko Kawano
    Chikako Shimizu
    Kenji Hashimoto
    Takayuki Kinoshita
    Hitoshi Tsuda
    Hirofumi Fujii
    Yasuhiro Fujiwara
    [J]. Breast Cancer, 2013, 20 : 145 - 151
  • [34] Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
    Tanya E. Keenan
    Jennifer L. Guerriero
    Romualdo Barroso-Sousa
    Tianyu Li
    Tess O’Meara
    Anita Giobbie-Hurder
    Nabihah Tayob
    Jiani Hu
    Mariano Severgnini
    Judith Agudo
    Ines Vaz-Luis
    Leilani Anderson
    Victoria Attaya
    Jihye Park
    Jake Conway
    Meng Xiao He
    Brendan Reardon
    Erin Shannon
    Gerburg Wulf
    Laura M. Spring
    Rinath Jeselsohn
    Ian Krop
    Nancy U. Lin
    Ann Partridge
    Eric P. Winer
    Elizabeth A. Mittendorf
    David Liu
    Eliezer M. Van Allen
    Sara M. Tolaney
    [J]. Nature Communications, 12
  • [35] Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer
    Kawano, Akiko
    Shimizu, Chikako
    Hashimoto, Kenji
    Kinoshita, Takayuki
    Tsuda, Hitoshi
    Fujii, Hirofumi
    Fujiwara, Yasuhiro
    [J]. BREAST CANCER, 2013, 20 (02) : 145 - 151
  • [36] Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
    Keenan, Tanya E.
    Guerriero, Jennifer L.
    Barroso-Sousa, Romualdo
    Li, Tianyu
    O'Meara, Tess
    Giobbie-Hurder, Anita
    Tayob, Nabihah
    Hu, Jiani
    Severgnini, Mariano
    Agudo, Judith
    Vaz-Luis, Ines
    Anderson, Leilani
    Attaya, Victoria
    Park, Jihye
    Conway, Jake
    He, Meng Xiao
    Reardon, Brendan
    Shannon, Erin
    Wulf, Gerburg
    Spring, Laura M.
    Jeselsohn, Rinath
    Krop, Ian
    Lin, Nancy U.
    Partridge, Ann
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Liu, David
    Van Allen, Eliezer M.
    Tolaney, Sara M.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [37] Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
    Shivapurkar, Narayan
    Vietsch, Eveline E.
    Carney, Erin
    Isaacs, Claudine
    Wellstein, Anton
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [38] Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
    Lee, Eunice Yoojin
    Lee, Dae-Won
    Lee, Kyung-Hun
    Im, Seock-Ah
    [J]. CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1065 - 1076
  • [39] DETERMINATION AND CLINICAL SIGNIFICANCE OF BONE PSEUDOPROGRESSION IN HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER
    Zhang, Jian
    Lin, Mingxi
    [J]. BREAST, 2021, 59 : S52 - S53
  • [40] Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer
    Ham, Ahrong
    Kim, Min Hwan
    Kim, Gun Min
    Kim, Jee Hung
    Kim, Jee Ye
    Park, Hyung Seok
    Park, Seho
    Cho, Young Up
    Park, Byeong Woo
    Kim, Seung Il
    Sohn, Joohyuk
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 107 - 116
12345